- Home
- INKT vs NMS Comparison
INKT vs NMS Comparison
Compare INKT & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INKT | NMS |
|---|---|---|
| Founded | 2017 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.4M | 63.1M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | INKT | NMS |
|---|---|---|
| Price | $10.83 | $10.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $39.00 | N/A |
| AVG Volume (30 Days) | 16.2K | ★ 25.2K |
| Earning Date | 11-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.65 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.48 | $9.48 |
| 52 Week High | $15.27 | $12.50 |
Technical Indicators
Market Signals| Indicator | INKT | NMS |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 49.14 |
| Support Level | $10.85 | $9.48 |
| Resistance Level | $12.38 | $10.15 |
| Average True Range (ATR) | 0.65 | 0.13 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 57.14 | 66.67 |
Price Performance
Historical ComparisonAbout INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The company has Single operating segment.